Market Currents
Jefferies analyst Raj Denhoy comes out defending Edwards Lifesciences (EW -6.5%) on weakness...
-
Tuesday, February 5, 2:56 PM ETJefferies analyst Raj Denhoy comes out defending Edwards Lifesciences (EW -6.5%) on weakness today, reiterating his Buy rating and upping his price target to $114 from $100. Denhoy says its quarter was solid, and the higher price target is due to strong US Sapien transcatheter heart valve sales, which are tracking ahead of expectations.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
